Global Hyaluronic Acid (HA) for Medical Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hyaluronic Acid (HA) for Medical Market Research Report 2024
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint.
According to Mr Accuracy reports new survey, global Hyaluronic Acid (HA) for Medical market is projected to reach US$ 323.2 million in 2029, increasing from US$ 162.8 million in 2022, with the CAGR of 10.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyaluronic Acid (HA) for Medical market research.
Due to the COVID-19 pandemic, the global Pharma-Grade Hyaluronic Acid market size is estimated to be worth US$ 163 million in 2022 and is forecast to a readjusted size of US$ 323 million by 2029 with a CAGR of 10.34% during the forecast period 2024-2034. The rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. However, adverse effects associated with treatment or therapy such as redness and itching, as well as an increase in the price of hyaluronic acid products, is expected to hamper the hyaluronic acid market's growth during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronic Acid (HA) for Medical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Segment by Type
Injection Product
Eye Drops
Medical Hygiene
Plastic Surgery
Health Products
Other
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Hyaluronic Acid (HA) for Medical report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Hyaluronic Acid (HA) for Medical market is projected to reach US$ 323.2 million in 2029, increasing from US$ 162.8 million in 2022, with the CAGR of 10.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyaluronic Acid (HA) for Medical market research.
Due to the COVID-19 pandemic, the global Pharma-Grade Hyaluronic Acid market size is estimated to be worth US$ 163 million in 2022 and is forecast to a readjusted size of US$ 323 million by 2029 with a CAGR of 10.34% during the forecast period 2024-2034. The rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. However, adverse effects associated with treatment or therapy such as redness and itching, as well as an increase in the price of hyaluronic acid products, is expected to hamper the hyaluronic acid market's growth during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronic Acid (HA) for Medical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Segment by Type
Injection Product
Eye Drops
Segment by Application
Medical Hygiene
Plastic Surgery
Health Products
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Hyaluronic Acid (HA) for Medical report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source